News-Medical.Net on MSN
Primerdesign launches exsig Mag RapidBead Pro Extraction kit for DNA and RNA
Primerdesign (part of the Novacyt Group), a company focused on the design, manufacture, validation and supply of real-time ...
Primerdesign has launched the exsig Mag RapidBead Pro Extraction kit, a magnetic bead-based kit that can be used to extract ...
Diagnostics, Inc. (NASDAQ: CODX) ("Co-Diagnostics," "Co-Dx," or "the Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, ...
Research and development expense in fiscal Q3 2025 -- $4.5 million versus $4.9 million in fiscal Q3 2024. Net loss -- $5.9 ...
Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented ...
Background Eosinophilic oesophagitis (EoE) is a chronic allergic disease characterised by oesophageal epithelial remodelling, barrier dysfunction and inflammation. The transcription factor forkhead ...
This article introduces the field of bioinformatics and its importance as a cornerstone of biological research, as well as its history from the comparative analysis of the first amino acid sequences ...
Improving the profiling of wheat bacterial and fungal endophytic communities—a PCR clamping approach
Background: Plant-associated endophytic microbial communities are an important source of biological diversity. To study them, efficient, robust, and standardized characterization methods are necessary ...
BIRMINGHAM, Ala., Nov. 18, 2025 /PRNewswire/ -- Molecular Designs, a developer and manufacturer of molecular infectious-disease assays, today announced the launch of its Human Papillomavirus (HPV) ...
Figure 1: Amplification of complex gene libraries by conventional PCR and emulsion PCR. Figure 2: Ethidium bromide–stained agarose gels reveal the absence of size competition and chimeric ...
Background Globally, an estimated 296 million individuals live with chronic hepatitis B virus (HBV) infection, carrying ...
ALL is the most common childhood cancer, and cases are rising. Find out why this trend is paired with a remarkable 90% survival rate, and what public health action is needed next.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results